Eyes treated with LPC for TR-ROP tend to have more myopic refraction than the eyes treated with intravitreal anti-VEGF injections, while the rates of adverse events, complications, unfavorable structural outcomes, and unfavorable neurodevelopmental outcomes between the two treatment modalities seem to be similar. Here, VEGFA is linked to retinopathy of prematurity.